Blood pressure changes with alemtuzumab in patients with multiple sclerosis


  • Significant increases in blood pressure occurred in people with multiple sclerosis (MS) who were receiving alemtuzumab infusion.

Why this matters

    During clinical trials, a common adverse event for individuals taking alemtuzumab was hypotension; however, changes in blood pressure during alemtuzumab infusion in people with MS is not well understood.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.